An important risk factor biomarker in the course of AD is RCAN1, and upregulation of RCAN1 is thought to result from oxidative stress caused by a combination of Tau phosphorylation and Aβ (Greenough et al., 2013; Chen and Zhong, 2014; Kim et al., 2015). The gene discussed is MAPT; the disease is Alzheimer disease.